alzheimersdisease
A potential game-changer in Alzheimer’s treatment has emerged from UCLA Health, where scientists have identified a compound that can restore memory function in mice with symptoms of the disease. This groundbreaking discovery, centered around a molecule called DDL-920, could pave the way for a novel approach to treating Alzheimer’s that goes beyond merely slowing the disease’s progression. The study, published in The Proceedings of the National Academy of Sciences, demonstrated that DDL-920 effectively “jumpstarted” the brain’s memory circuitry. Alzheimer’s disease is a progressive neurological...
PsyPost
A potential game-changer in Alzheimer’s treatment has emerged from UCLA Health, where scientists have identified a compound that can restore memory function in mice with symptoms of the disease. This groundbreaking discovery, centered around a molecule called DDL-920, could pave the way for a novel approach to treating Alzheimer’s that goes beyond merely slowing the disease’s progression. The study, published in The Proceedings of the National Academy of Sciences, demonstrated that DDL-920 effectively “jumpstarted” the brain’s memory circuitry. Alzheimer’s disease is a progressive neurological...
PsyPost (CA)
A potential game-changer in Alzheimer’s treatment has emerged from UCLA Health, where scientists have identified a compound that can restore memory function in mice with symptoms of the disease. This groundbreaking discovery, centered around a molecule called DDL-920, could pave the way for a novel approach to treating Alzheimer’s that goes beyond merely slowing the disease’s progression. The study, published in The Proceedings of the National Academy of Sciences, demonstrated that DDL-920 effectively “jumpstarted” the brain’s memory circuitry. Alzheimer’s disease is a progressive neurological...
PsyPost (UK)
The genetic risk of developing Alzheimer’s disease is more strongly influenced by the mother’s side than the father’s side, a recent study has discovered. Alzheimer’s disease steals memories, independence and the capacity to connect with loved ones. In 2020, over 55 million people worldwide were living with dementia. Alzheimer’s disease is the most common form of dementia, accounting for 60-70% of all dementias. It’s expected the number of people affected by dementia will nearly double every 20 years. Finding ways to better diagnose, treat and even prevent dementia is more important than ever....
PsyPost
The genetic risk of developing Alzheimer’s disease is more strongly influenced by the mother’s side than the father’s side, a recent study has discovered. Alzheimer’s disease steals memories, independence and the capacity to connect with loved ones. In 2020, over 55 million people worldwide were living with dementia. Alzheimer’s disease is the most common form of dementia, accounting for 60-70% of all dementias. It’s expected the number of people affected by dementia will nearly double every 20 years. Finding ways to better diagnose, treat and even prevent dementia is more important than ever....
PsyPost (CA)
The genetic risk of developing Alzheimer’s disease is more strongly influenced by the mother’s side than the father’s side, a recent study has discovered. Alzheimer’s disease steals memories, independence and the capacity to connect with loved ones. In 2020, over 55 million people worldwide were living with dementia. Alzheimer’s disease is the most common form of dementia, accounting for 60-70% of all dementias. It’s expected the number of people affected by dementia will nearly double every 20 years. Finding ways to better diagnose, treat and even prevent dementia is more important than ever....
PsyPost (UK)
Scientists have uncovered a significant clue to understanding why some individuals are more susceptible to Alzheimer’s disease. Published in the journal Nature Communications, this new research reveals how a genetic variant called apolipoprotein E (APOE) interacts with a protein known as amyloid-beta. This interaction influences the likelihood of developing Alzheimer’s disease. Specifically, the study highlights that the APOE4 variant increases the harmful effects of amyloid-beta accumulation in the brain, providing a potential target for new therapies. Alzheimer’s disease is a debilitating ne...
PsyPost (CA)
Scientists have uncovered a significant clue to understanding why some individuals are more susceptible to Alzheimer’s disease. Published in the journal Nature Communications, this new research reveals how a genetic variant called apolipoprotein E (APOE) interacts with a protein known as amyloid-beta. This interaction influences the likelihood of developing Alzheimer’s disease. Specifically, the study highlights that the APOE4 variant increases the harmful effects of amyloid-beta accumulation in the brain, providing a potential target for new therapies. Alzheimer’s disease is a debilitating ne...
PsyPost
Scientists have uncovered a significant clue to understanding why some individuals are more susceptible to Alzheimer’s disease. Published in the journal Nature Communications, this new research reveals how a genetic variant called apolipoprotein E (APOE) interacts with a protein known as amyloid-beta. This interaction influences the likelihood of developing Alzheimer’s disease. Specifically, the study highlights that the APOE4 variant increases the harmful effects of amyloid-beta accumulation in the brain, providing a potential target for new therapies. Alzheimer’s disease is a debilitating ne...
PsyPost (UK)
Could your personality influence your risk of developing Alzheimer’s disease? An analysis of UK Biobank data showed that individuals with amnestic mild cognitive impairment who also have high genetic risk for neuroticism are more likely to develop Alzheimer’s disease. Researchers used genetic data to calculate a neuroticism risk score and found that individuals with higher scores were more prone to developing Alzheimer’s. The paper was published in Human Brain Mapping. Amnestic mild cognitive impairment is a condition characterized by noticeable memory problems that are more severe than typica...
PsyPost (CA)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら